nDatalyze Corp ( (TSE:NDAT) ) has provided an announcement.
nDatalyze Corp. has announced ongoing progress in its Reverse Takeover with ThriveTech Holdings, with discussions continuing regarding share distribution post-RTO. Additionally, the company is nearing the launch of ‘Sigmund,’ a new product line targeting the EMR, concierge medical, and performance coaching markets, which integrates AI and DNA-based mental condition assessments.
More about nDatalyze Corp
nDatalyze Corp. operates in the technology sector, focusing on AI-augmented mental condition assessments and proprietary DNA panels. The company is expanding its offerings to include products for the electronic medical record, concierge medical, and performance coaching markets.
YTD Price Performance: -68.75%
Average Trading Volume: 70,705
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$1.03M
For detailed information about NDAT stock, go to TipRanks’ Stock Analysis page.